Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial
Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial
NCT ID: NCT06221605 Phase: NA Status: COMPLETED Enrollment: 84 Completion: 2025-04-11
Conditions
Chronic Hepatitis B
Interventions
Probiotic
Summary
The goal of this is to verify the clinical efficacy of compound probiotics in reducing HBV infection levels and regulating intestinal flora in patients with chronic hepatitis B.
The main question it aims to answer is:
• Conventional antiviral therapy combined with a 3-month probiotic intervention was used to evaluate the clinical efficacy of reducing HBV infection levels (HBeAg, HBsAg, and HBV DNA levels) and regulating gut microbiota.
Primary Outcome
Test the level of HBV infection in chronic hepatitis B patients